Bixiye
QP69-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Risdiplam
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2481 - 2490 ee natiijooyinka 3289
Bixiye
QP65-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Satralizumab
Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020
Bixiye
QP61-20 Signify Health Virtual Visits for Medicare Advantage and SecureBlue Members
Taariikhda dhaqangalka Barnaamijka: Jul 08, 2020
Bixiye
QP58-20 Commercial Pharmacy Benefit Exclusion for Medical Drugs Anjeso™ , Fetroja™ and Potassium Phosphates
Taariikhda dhaqangalka Barnaamijka: Jul 08, 2020
Bixiye
QP59-20 MHCP Pharmacy Benefit Exclusion for DurystaTM and Fensolvi®
Taariikhda dhaqangalka Barnaamijka: Jul 08, 2020
Bixiye
QP60-20 Commercial Pharmacy Benefit Exclusion for Procysbi® Delayed-Release Granules
Taariikhda dhaqangalka Barnaamijka: Jul 08, 2020
Bixiye
P46-20 Genetic/Molecular Lab Test Coding Reimbursement Policy
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Bixiye
P52-20 Emergency Department Level of Service Coding Reimbursement Policy
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Bixiye
P53-20 New Reimbursement Policy: Inpatient Non-Reimbursable Unbundling
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020
Bixiye
P48-20 CMS Issued Prior Authorization Requirements for Certain Hospital Outpatient Department (OPD) Services – Effective July 1, 2020
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2020